Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes.
Endresen, Gerhard K M · Rheumatology international · 2003 · DOI
Quick Summary
This review looked at whether a type of bacteria called mycoplasma might be found in the blood of people with ME/CFS and fibromyalgia. Researchers found mycoplasma in about half of patients with these conditions, compared to only 10% of healthy people. Some patients who received long-term antibiotic treatment appeared to recover completely, suggesting mycoplasma infection might be treatable in certain cases.
Why It Matters
This research addresses a longstanding challenge in ME/CFS: the lack of consistent biomarkers. If mycoplasma infection accounts for a significant subset of cases, it could enable better patient subclassification and targeted treatment, potentially explaining why some patients respond to antibiotics while others do not.
Observed Findings
Mycoplasma detected via PCR in approximately 50% of CFS and/or FMS patients
Mycoplasma detected in approximately 10% of healthy control individuals
Patients with mycoplasma infection who received long-term doxycycline therapy appeared to recover and reach pre-illness baseline
Mycoplasma infection became undetectable after recovery in treated patients
Overlap between mycoplasma detection and Gulf War illness symptomatology
Inferred Conclusions
Mycoplasma blood infection may represent a distinct biological subtype within CFS and FMS populations
Long-term antibiotic therapy may be effective for the mycoplasma-positive subgroup
Mycoplasma detection could permit improved subclassification of CFS and FMS for clinical and research purposes
Mycoplasma prevalence in CFS/FMS substantially exceeds that in healthy populations
Remaining Questions
Is mycoplasma a causal agent, cofactor, or opportunistic infection in ME/CFS and fibromyalgia?
Can the 50% detection rate be replicated across diverse geographic, demographic, and clinical patient populations?
What This Study Does Not Prove
This review does not establish causality—mycoplasma detection does not prove the bacteria caused ME/CFS or fibromyalgia. The study cannot determine whether mycoplasma is a primary pathogen, a secondary infection due to immune dysfunction, or simply a bystander. The findings also require replication across diverse patient populations before broad clinical application.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.